NKCx Histopathological outcome* within 12 months after cervix cytology in 2018 |
521 Borås |
Benign | CIN1 | CIN2 | CIN3 | AIS | Cancer | Other | PAD missing | Total | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cytology | Count | Pct | Count | Pct | Count | Pct | Count | Pct | Antal | Andel | Count | Pct | Count | Pct | Count | Pct | Count | Pct |
Benign sample | 52 | 0.3% | 2 | 0.0% | . | . | . | . | 1 | 0.0% | . | . | 1 | 0.0% | 15498 | 99.6% | 15554 | 100.0% |
ASCUS | 49 | 9.8% | 54 | 10.8% | 1 | 0.2% | 37 | 7.4% | . | . | . | . | 1 | 0.2% | 356 | 71.5% | 498 | 100.0% |
CIN1 | 29 | 16.5% | 36 | 20.5% | . | . | 26 | 14.8% | . | . | . | . | 2 | 1.1% | 83 | 47.2% | 176 | 100.0% |
Atypical glandular cells/AGC | 1 | 14.3% | 1 | 14.3% | . | . | 1 | 14.3% | 2 | 28.6% | . | . | . | . | 2 | 28.6% | 7 | 100.0% |
ASC-H | 4 | 12.1% | 2 | 6.1% | . | . | 20 | 60.6% | 2 | 6.1% | 1 | 3.0% | . | . | 4 | 12.1% | 33 | 100.0% |
CIN3 | 7 | 6.1% | 6 | 5.3% | . | . | 88 | 77.2% | 4 | 3.5% | 4 | 3.5% | . | . | 5 | 4.4% | 114 | 100.0% |
Adenocarcinoma | . | . | . | . | . | . | . | . | . | . | 1 | 100.0% | . | . | . | . | 1 | 100.0% |
Total | 142 | 0.9% | 101 | 0.6% | 1 | 0.0% | 172 | 1.0% | 9 | 0.1% | 6 | 0.0% | 4 | 0.0% | 15948 | 97.3% | 16383 | 100.0% |
NOTE: Histopathological outcome from T83x taken into account. |
This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad. |
* Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead. |
The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'. |
Process Registry's Class 1 (benign), 2d (CIN1) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories. |
Snomed codes in the category Cancer: |
---|
M80703, M81403 |